Bacterial Gastroenteritis Clinical Presentation
- Author: Jennifer Lynn Bonheur, MD; Chief Editor: Julian Katz, MD more...
History
Stool characteristics
Diarrhea is defined as daily stools with a mass greater than 15g/kg for children younger than 2 years and greater than 200 g for children 2 years or older. Adult stool patterns vary from 1 stool every 3 days to 3 stools per day; therefore, consider individual stool patterns.
Consistency, color, volume, and frequency are very important in determining whether the stool source is from the small or large bowel. Table 1, below, outlines these characteristics and demonstrates that an index of suspicion can be generated easily for a specific set of organisms.
Table 1. Stool Characteristics and Sources (Open Table in a new window)
| Stool Characteristics | Small Bowel | Large Bowel |
| Appearance | Watery | Mucus and/or blood |
| Volume | Large | Small |
| Frequency | Increased | Increased |
| Blood | Possibly heme-positive but never gross blood | Possibly grossly bloody |
| pH | Possibly < 5.5 | >5.5 |
| Reducing substances | Possibly positive | Negative |
| White blood cell (WBC) count | < 5/high-power field (HPF) | Possibly >10/HPF |
| Serum WBC count | Normal | Possible leukocytosis, bandemia |
| Organisms | Preformed toxins: Bacillus species, Staphylococcus aureus | Invasive bacteria: E coli and Shigella, Salmonella, Campylobacter, Yersinia, Aeromonas, and Plesiomonas species |
| Toxic bacteria: E coli, cholera, C perfringens, Vibrio species, Listeria monocytogenes | Toxic bacteria: C difficile | |
| Other causes: rotavirus, adenovirus, calicivirus, astrovirus, Norwalk virus, and Giardia and Cryptosporidium species | Other causes: Entamoeba species |
Systemic symptoms
Associated systemic symptoms can guide empiric therapy. Some enteric infections have characteristic systemic symptoms, whereas the associated systemic features of others do not occur reliably. Table 2, below, outlines the frequency of these symptoms with various organisms.
The characteristics of symptom onset and symptom duration can narrow the differential diagnosis of the organism. The onset of symptoms within 6 hours of exposure to the bacterial source indicates a preformed toxin, probably produced by a species of Staphylococcus or Bacillus. Table 2 outlines the incubation periods and durations of common bacteria.
Table 2. Symptoms and Their Characteristics (Open Table in a new window)
| Organism | Incubation | Duration | Vomiting | Fever | Abdominal Pain |
| Aeromonas species | None | 0-2 weeks | +/- | +/- | No |
| Bacillus species | 1-16 hours | 1-2 days | Yes | No | Yes |
| Campylobacter species | 2-4 days | 5-7 days | No | Yes | Yes |
| C difficile | Variable | Variable | No | Few | Few |
| C perfringens | 0-1 | 1 day | Mild | No | Yes |
| Enterohemorrhagic E coli | 1-8 days | 3-6 days | No | +/- | Yes |
| Enterotoxigenic E coli | 1-3 days | 3-5 days | Yes | Low | Yes |
| Listeria species | 20 hours | 2 days | Few | Yes | +/- |
| Plesiomonas species | None | 0-2 weeks | +/- | +/- | +/- |
| Salmonella species | 0-3 days | 2-7 days | Yes | Yes | Yes |
| Shigella species | 0-2 days | 2-7 days | No | High | Yes |
| S aureus | 2-6 hours | 1 day | Yes | No | Yes |
| Vibrio species | 0-1 days | 5-7 days | Yes | No | Yes |
| Y enterocolitica | 0-6 | 1-46 days | Yes | Yes | Yes |
Food-borne bacteria
Particular foods are associated with certain bacteria. Ingestion of raw or contaminated food, particularly raw milk and meat, is a common cause of bacterial gastroenteritis. The following list outlines organisms that cause food poisoning:
- Dairy -Campylobacter, Salmonella, Listeria, and Staphylococcus species
- Eggs -Salmonella species
- Meats -C perfringens and Salmonella, Aeromonas, Campylobacter, and Staphylococcus species
- Ground beef - Enterohemorrhagic E coli
- Poultry -Campylobacter species
- Pork -C perfringens and Y enterocolitica
- Seafood -Aeromonas, Plesiomonas, and Vibrio species and astrovirus
- Oysters -Plesiomonas and Vibrio species and calicivirus
- Vegetables -Aeromonas species and C perfringens
- Alfalfa sprouts - Enterohemorrhagic E coli and Salmonella species
- Fried rice -Bacillus species
- Custards, mayonnaise -Staphylococcus species
A study by Calbo et al reported a foodborne nosocomial outbreak due to extended-spectrum β-lactamase (ESBL)–producing Klebsiella pneumoniae.[14] This may be the first reported hospital outbreak that provides evidence that food can be a transmission vector for ESBL K pneumoniae.
Water-borne bacteria
Water is a major reservoir for many organisms that cause diarrhea. Swimming pools have been associated with outbreaks of Shigella organisms, and Aeromonas species are associated with exposure to the marine environment.
Animal-borne bacteria
Animals can transmit particular bacteria. Exposure to young dogs or cats is associated with Campylobacter transmission. Exposure to turtles is associated with Salmonella transmission.
Travel-associated infections
Travel history is an important and useful clue in determining bacterial etiology. Enterotoxigenic E coli is the leading cause of traveler's diarrhea. Rotavirus and Shigella, Salmonella, and Campylobacter species are prevalent worldwide and need to be considered, regardless of specific travel history.
The risk of contracting diarrhea while traveling is highest in travel to Africa. Travel to Portugal, Spain, and Eastern European countries is also associated with a relatively high risk. Organisms associated with travel to particular locations are as follows:
- Nonspecific - Enterotoxigenic E coli and Aeromonas, Giardia, Plesiomonas, Salmonella, and Shigella species
- Developing tropics -C perfringens
- Africa -Entamoeba species and Vibrio cholerae
- Americas (South and Central) -Entamoeba species and V cholerae
- Asia -V cholerae
- Australia -Yersinia species
- Canada -Yersinia species
- Europe -Yersinia species
- India -Entamoeba species and V cholerae
- Japan -V parahaemolyticus
- Mexico -Aeromonas, Entamoeba, Plesiomonas, and Yersinia species
- New Guinea -Clostridium species
Bacteria associated with preexisting conditions
Preexisting medical conditions can predispose patients for infections with particular organisms. The following list outlines such medical conditions and their associated organisms:
- C difficile - Hospitalization with antibiotic administration
- Plesiomonas species - Liver diseases or malignancy
- Salmonella species - Intestinal dysmotility, malnutrition, achlorhydria, hemolytic anemia (especially sickle cell disease), immunosuppression, and malaria
- Rotavirus - Hospitalization
- Giardia species - Agammaglobulinemia, chronic pancreatitis, achlorhydria, and cystic fibrosis
- Cryptosporidia - Immunocompromise and immunosuppression
Outbreaks
Outbreaks are caused by particular bacteria, including enterohemorrhagic E coli O157:H7, Listeria monocytogenes, C perfringens, and Salmonella species.
Physical Examination
Dehydration is the primary cause of morbidity and mortality in cases of gastroenteritis. Assess every patient for signs, symptoms, and severity of dehydration. Lethargy, depressed consciousness, dry mucous membranes, sunken eyes, poor skin turgor, and delayed capillary refill should raise the suspicion for dehydration.
Malnutrition is typically a sign of a chronic process. Reduced muscle and fat mass is found. This is usually due to the development of secondary carbohydrate intolerance.
Abdominal pain is a common symptom in gastroenteritis. Nonspecific, nonfocal abdominal pain and cramping are common with some organisms. This pain usually does not increase with palpation. Focal abdominal pain worsened by palpation, rebound tenderness, or guarding should alert the clinician to possible complications or to another noninfectious gastrointestinal diagnosis.
Borborygmi, defined as a significant increase in peristaltic activity with small bowel diarrhea, can cause an audible and/or palpable increase in bowel activity.
Perianal erythema results from many stools causing a constantly wet area. Failure to properly dry the buttocks and perianal area results in erythema and skin breakdown.
Salminen S, Isolauri E, Onnela T. Gut flora in normal and disordered states. Chemotherapy. 1995;41 suppl 1:5-15. [Medline].
Marks MI. Infectious diarrhea: introduction and commentary. Pediatr Ann. Oct 1994;23(10):526-7. [Medline].
Liebelt EL. Clinical and laboratory evaluation and management of children with vomiting, diarrhea, and dehydration. Curr Opin Pediatr. Oct 1998;10(5):461-9. [Medline].
Hamer DH, Gorbach SL. Infectious diarrhea and bacterial food poisoning. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisinger and Fordtran's Gastrointestinaland Liver Disease. 6th ed. Philadelphia, Pa: WB Saunders; 1998:1594-1632.
Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm. Nov 15 2007;64(22):2359-63. [Medline].
Steffen R, Collard F, Tornieporth N, et al. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA. Mar 3 1999;281(9):811-7. [Medline]. [Full Text].
Streit JM, Jones RN, Toleman MA, Stratchounski LS, Fritsche TR. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int J Antimicrob Agents. May 2006;27(5):367-75. [Medline].
Vital Signs: Preventing Clostridium difficile Infections. MMWR Morb Mortal Wkly Rep. Mar 9 2012;61:157-62. [Medline].
World Health Organization. Cholera: fact sheet no. 107. November 2008. Available at http://www.who.int/mediacentre/factsheets/fs107/en/. Accessed February 19, 2009.
Lee LA, Gerber AR, Lonsway DR, et al. Yersinia enterocolitica O:3 infections in infants and children, associated with the household preparation of chitterlings. N Engl J Med. Apr 5 1990;322(14):984-7. [Medline].
Centers for Disease Control and Prevention. Yersinia enterocolitica. October 25, 2005. Available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/yersinia_g.htm. Accessed February 18, 2009.
Centers for Disease Control and Prevention (CDC). Deaths from gastroenteritis double. Available at http://www.cdc.gov/media/releases/2012/p0314_gastroenteritis.html.
Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. May 2006;130(6):1588-94. [Medline].
Calbo E, Freixas N, Xercavins M, Riera M, Nicolás C, Monistrol O, et al. Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis. Mar 2011;52(6):743-9. [Medline].
Cody SH, Abbott SL, Marfin AA, et al. Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northern California. JAMA. May 19 1999;281(19):1805-10. [Medline]. [Full Text].
World Health Organization. Drug-resistant Salmonella: fact sheet no. 139. Revised April 2005. Available at http://www.who.int/mediacentre/factsheets/fs139/en/. Accessed February 19, 2009.
Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. Jan 2000;30(1):54-60. [Medline].
Simakachorn N, Pichaipat V, Rithipornpaisarn P, et al. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr. Jan 2000;30(1):68-72. [Medline].
Duggan C, Nurko S. "Feeding the gut": the scientific basis for continued enteral nutrition during acute diarrhea. J Pediatr. Dec 1997;131(6):801-8. [Medline].
Guandalini S, Dincer AP. Nutritional management in diarrhoeal disease. Baillieres Clin Gastroenterol. Dec 1998;12(4):697-717. [Medline].
Sullivan PB. Nutritional management of acute diarrhea. Nutrition. Oct 1998;14(10):758-62. [Medline].
[Best Evidence] Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al, for the Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. Jan 5 2006;354(1):11-22. [Medline]. [Full Text].
DuPont HL, The Practice Parameters Committee of the American College of Gastroenterology. Guidelines on acute infectious diarrhea in adults. Am J Gastroenterol. Nov 1997;92(11):1962-75. [Medline].
Garcia Rodriguez LA, Ruigomez A, Panes J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol. Dec 2007;5(12):1418-23. [Medline].
Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother. Aug 2006;58(2):243-55. [Medline]. [Full Text].
Kaur S, Vaishnavi C, Prasad KK, Ray P, Kochhar R. Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice. Microbiol Immunol. 2007;51(12):1209-14. [Medline]. [Full Text].
Mines D, Stahmer S, Shepherd SM. Poisonings: food, fish, shellfish. Emerg Med Clin North Am. Feb 1997;15(1):157-77. [Medline].
Nataro JP, Steiner T, Guerrant RL. Enteroaggregative Escherichia coli. Emerg Infect Dis. Apr-Jun 1998;4(2):251-61. [Medline].
Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med. Jun 2006;119(6 suppl 1):S20-8; discussion S62-70. [Medline].
Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. Feb 27 1999;318(7183):565-6. [Medline]. [Full Text].
Trachtman H, Christen E. Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome. Curr Opin Pediatr. Apr 1999;11(2):162-8. [Medline].
Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. Jun 29 2000;342(26):1930-6. [Medline]. [Full Text].
| Stool Characteristics | Small Bowel | Large Bowel |
| Appearance | Watery | Mucus and/or blood |
| Volume | Large | Small |
| Frequency | Increased | Increased |
| Blood | Possibly heme-positive but never gross blood | Possibly grossly bloody |
| pH | Possibly < 5.5 | >5.5 |
| Reducing substances | Possibly positive | Negative |
| White blood cell (WBC) count | < 5/high-power field (HPF) | Possibly >10/HPF |
| Serum WBC count | Normal | Possible leukocytosis, bandemia |
| Organisms | Preformed toxins: Bacillus species, Staphylococcus aureus | Invasive bacteria: E coli and Shigella, Salmonella, Campylobacter, Yersinia, Aeromonas, and Plesiomonas species |
| Toxic bacteria: E coli, cholera, C perfringens, Vibrio species, Listeria monocytogenes | Toxic bacteria: C difficile | |
| Other causes: rotavirus, adenovirus, calicivirus, astrovirus, Norwalk virus, and Giardia and Cryptosporidium species | Other causes: Entamoeba species |
| Organism | Incubation | Duration | Vomiting | Fever | Abdominal Pain |
| Aeromonas species | None | 0-2 weeks | +/- | +/- | No |
| Bacillus species | 1-16 hours | 1-2 days | Yes | No | Yes |
| Campylobacter species | 2-4 days | 5-7 days | No | Yes | Yes |
| C difficile | Variable | Variable | No | Few | Few |
| C perfringens | 0-1 | 1 day | Mild | No | Yes |
| Enterohemorrhagic E coli | 1-8 days | 3-6 days | No | +/- | Yes |
| Enterotoxigenic E coli | 1-3 days | 3-5 days | Yes | Low | Yes |
| Listeria species | 20 hours | 2 days | Few | Yes | +/- |
| Plesiomonas species | None | 0-2 weeks | +/- | +/- | +/- |
| Salmonella species | 0-3 days | 2-7 days | Yes | Yes | Yes |
| Shigella species | 0-2 days | 2-7 days | No | High | Yes |
| S aureus | 2-6 hours | 1 day | Yes | No | Yes |
| Vibrio species | 0-1 days | 5-7 days | Yes | No | Yes |
| Y enterocolitica | 0-6 | 1-46 days | Yes | Yes | Yes |
| Organism | Detection Method | Microbiologic Characteristics |
| Aeromonas species | Blood agar | Oxidase-positive, flagellated GNB |
| Bacillus species | Blood agar | Facultatively aerobic, spore-forming GPR; beta hemolytic; reduces nitrates; ferments carbohydrates |
| Campylobacter species | Skirrow agar | Rapidly motile, curved GNR; Campylobacter jejuni 90% of infections, Campylobacter coli 5% of infections |
| C difficile | CCFE agar, EIA for toxin, LA for protein | Anaerobic, spore-forming GPR; toxin-mediated diarrhea; produces pseudomembranous colitis |
| C perfringens | None available | Anaerobic, spore-forming GPR; toxin-mediated diarrhea |
| E coli | MacConkey, EMB, or SM agar | Lactose-producing GNR |
| Listeria species | Blood agar | Flagellated GPB |
| Plesiomonas species | Blood agar | Oxidase-positive GNR |
| Salmonella species | Blood, MacConkey, EMB, XLD, or HE agar | Nonlactose, non–H2S-producing GNR |
| Shigella species | Blood, MacConkey, EMB, XLD, or HE agar | Nonlactose and H2S-producing GNR; verotoxin (neurotoxin) |
| Staphylococcus species | Blood agar | Heat-stable, preformed toxin-mediated GPC |
| Vibrio species | Blood or TCBS agar | Oxidase-positive, motile, curved GNB |
| Y enterocolitica | CIN agar | Nonlactose-producing, oval GNR |
| CCFE = cycloserine-cefoxitin-fructose-egg; CIN = cefsulodin-irgasan-novobiocin; EIA= enzyme immunoassay; EMB = e-methylene blue; GNB = gram-negative bacillus; GNR = gram-negative rod; GPB = gram-positive bacillus; GPC = gram-positive cocci; GPR = gram-positive rod; H2S = hydrogen sulfide; HE = Hektoen enteric; LA = latex agglutination; SM = Sorbitol-MacConkey; TCBS = thiosulfate-citrate-bile-sucrose; XLD = xylose-lysine-deoxycholate. | ||

